Rajesh Dave, distinguished professor of chemical, biological and pharmaceutical engineering, and two of his former graduate students, Maxx Capece and Daniel To, have been tapped to receive the Thomas Alva Edison Patent Award from the Research & Development Council of New Jersey for developing a manufacturing process that masks the bitter tastes of medications while delivering them effectively to their targets in the body.
The team of chemical engineers will be honored for their "enabling technology" at the organization's 37th Edison Patent Awards Ceremony on November 3. They are among 12 winners this year.
Their patent, "Solventless Mixing Process for Coating Pharmaceutical Ingredients" (U.S. 9,107,851), is for a process that combines water insoluble and soluble polymers to form a highly structured particle coating layer, spread as a composite film in a single, high intensity, vibratory process so that the bitter task of the drug is masked, while not impeding its delivery.
The process allows them to coat fine particles less than the diameter of a human hair in width without using water, organic solvents or heat. The technology has been licensed by a global health care company that develops both drugs and their delivery systems. The coating in that instance is a fine layer of wax that will be used to mask bitter tastes.
Capece is a senior scientist at Chicago-based AbbVie, Inc., a biopharmaceutical company, and To is senior product development scientist at Colorcon, Inc., a global pharmaceutical product development company. Both worked with Dave at the New Jersey Center for Engineered Particulates while they were Ph.D. students at NJIT.
"This year's individual and patent award winners showcase the breadth and depth of STEM leadership and innovation in New Jersey," said R&D Council President Anthony Cicatiello in a release this week. "New Jersey is STEM strong. Dating back to the beginning with Edison, then Bell Labs and our state's robust pharmaceutical industry, jumping to present day inventions and discoveries like those we are honoring in this year's Edison Awards class, New Jersey continues to be an innovation powerhouse."
The Council's awards this year will go to innovative patent work spanning 11 categories, including agriculture, biotechnology, defense, drug delivery technology, enabling technology, energy, industrial process, industrial product, medical device, medical technology and telecommunications.
Among the other recipients are AdvanSix (Honeywell), ExxonMobil, Immunomedics, Lockheed Martin, Merck, NJIT, Nokia Bell Labs, Princeton Plasma Physics Laboratory, Rutgers University Siemens and TE Connectivity.
One of the nation's leading public technological universities, New Jersey Institute of Technology (NJIT) is a top-tier research university that prepares students to become leaders in the technology-dependent economy of the 21st century. NJIT's multidisciplinary curriculum and computing-intensive approach to education provide technological proficiency, business acumen and leadership skills. With an enrollment of 11,400 graduate and undergraduate students, NJIT offers small-campus intimacy with the resources of a major public research university. NJIT is a global leader in such fields as solar research, nanotechnology, resilient design, tissue engineering, and cybersecurity, in addition to others. NJIT ranks 5th among U.S. polytechnic universities in research expenditures, topping $121 million, and is among the top 1 percent of public colleges and universities in return on educational investment, according to PayScale.com. NJIT has a $1.74 billion annual economic impact on the State of New Jersey.